Delivery Order SPE2DB25D3022-SPE2DB25FWCQU
Award Date 9/19/25
Potential Completion Date 9/22/25
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,406.11 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count unit dose packages). This competitive award, made on September 16, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 17, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a Janus kinase...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,334.98 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose). This firm fixed-price, competitively awarded contract with no set-aside designation is scheduled for completion by August 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a Janus kinase inhibitor used to treat inflammatory and...
- The Defense Logistics Agency awarded a delivery order valued at $4,724.63 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose packaging) on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $60.3K to AmerisourceBergen Drug Corp for RINVOQ ER 45 MG tablets (UU 28S) with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a JAK inhibitor used to treat rheumatoid arthritis and other inflammatory...
- The Defense Logistics Agency awarded a delivery order valued at $29,328.80 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose packaging) on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed price, competitively awarded delivery order represents non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,396.70 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $7,154.87 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was awarded competitively with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) valued at $37,258.50. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The contract is set to conclude on September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a JAK...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,138.54 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on July 28, 2025, with completion targeted for July 29, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026 that provides comprehensive pharmaceutical and...
- The Defense Logistics Agency awarded a delivery order valued at $10,006.04 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on July 21, 2025, with completion expected by July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a Janus kinase inhibitor used to treat rheumatoid arthritis and other...